Technology | August 04, 2011

Atomlab Offers Speed, Efficiency, Storage and Control in Nuclear Pharmacies

August 4, 2011 – To improve patient health through safe and efficient use of radioactive materials during handling, diagnosis and therapy, many nuclear pharmacies use the Biodex Medical Systems’ Atomlab dose calibrator. Biodex spoke with Brett Whittacre, president of BioDose, Las Vegas, a provider of nuclear medicine management systems, about some of the objectives of a busy pharmacy and how the Atomlab’s new features can help hospitals and labs meet their goals.

The Atomlab has some recent enhancements, including quality assurance (QA) apps that bring individualized functions to the system; linearity decay and constancy measurements with an automated graphing feature; and increased storage capacity.

Software providers like BioDose have developed cost-effective programs to provide accurate solutions for computer isotope tracking needs. When working with radioactive materials, leading facilities turn to a system that is simple to operate, but can provide fast, accurate radionuclide activity measurements. So when it was time to look at technology to accomplish this, BioDose turned to Biodex for solutions.

BioDose provides software programs to nuclear pharmacists. One of the company’s software offerings is called the BioRx Pharmacy System. Atomlab Dose Calibrators are an integrated part of this system to communicate with BioDose as well as other widely recognized commercial nuclear medicine management systems.

In the early stages of development, Brett Whittacre worked on the communication protocols between software and hardware to ensure its reliability as a system able to perform under the most demanding conditions.

“The Atomlab and BioDose communication protocol provides increased efficiency and time savings with each dose. We saw substantial gains … This is so important to commercial nuclear pharmacies because over the course of a day, these savings really add up,” explained Whittacre.

With more and more nuclear medicine departments going electronic and turning to hot lab management in their pharmacies, hospitals and other nuclear facilities, interfacing with either the nuclear management information system (NMIS) or the BioRx software needed to be accomplished.

“This feature is found in all the Atomlab Dose Calibrators from Biodex. The Atomlab interfaces with all of our hot lab management and pharmacy solutions while storing records for inspectors. This is a real-time inventory system,” said Whittacre.

While BioDose’s software can communicate with dose calibrators, another important feature was having the dose calibrator transmit to a computer. There are only a few dose calibrators that can transmit to a computer; Biodex is one of them. Another time-saving feature is for the commercial laboratory.

Using NMIS or BioRx programs together provides optimal control over wipe test counting and constancy. The data is stored as reports in the management system’s software.

For more information: www.biodex.com/dosecalibrators

Related Content

Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Imaging | August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Study Demonstrates First Human Application of Novel PET Tracer for Prostate Cancer

Transaxial 11Csarcosine hybrid PET/CT showed a (triangulated) adenocarcinoma in the transition zone of the anterior right prostate gland on PET (A), CT (B), and a separately obtained T2?weighted MR sequence (C) with resulting PET/MRI registration (D). Image courtesy of M. Piert et al., University of Michigan, Ann Arbor, Mich.

News | Radiopharmaceuticals and Tracers | August 16, 2017
In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the...
PET/CT Tracer Identifies Vulnerable Lesions in Non-Small Cell Lung Cancer Patients

Example of a patient with an upper left lung NSCLC: A: FDG; B: FDG PET/CT; C: Planning radiotherapy based on FDG (66Gy) with BTVm (GTV), CTV and PTV; D: PET FMISO E: FMISO PET/CT; F: boost based on the FMISO PET (76Gy) with BTVh (biological hypoxic target volume) and PTV boost. Credit: QuantIF – LITIS EA 4108 – FR CNRS 3638, Henri Becquerel Cancer Center, Rouen, France

News | PET-CT | July 14, 2017
July 14, 2017 — Fluorine-18 (18F)-fluoromisonidazole (FMISO) is a positron emission tomography (PET)...
Novel PET Tracer Detects Small Blood Clots

PET images (MIP 0-60 min) of three Cynomolgus monkeys. Strong signals are detected at the sites where inserted catheters had roughened surfaces. Almost no other background signal is visible. Only accumulation in the gallbladder becomes visible at the bottom of the image. Credit: Piramal Imaging GmbH, Berlin Germany.

News | PET Imaging | July 07, 2017
July 7, 2017 — Blood clots in veins a
Sponsored Content | Videos | Clinical Decision Support | June 29, 2017
Rami Doukky, M.D., system chair, Division of Cardiology, professor of medicine, Cook County Health and Hospitals Syst
RaySafe Introduces Pro-Slit Camera for Accurate Focal Spot Measurement
Technology | Digital Radiography (DR) | June 27, 2017
Unfors RaySafe recently introduced the RaySafe Pro-Slit Phantom and the RaySafe Pro-Stand.
Dual-Agent PET/MR With Time of Flight Detects More Cancer

Tc-99m MDP bone scan (left) is negative for osseous lesions. NaF/FDG PET/MRI (right and second slide) confirms absence of bone metastases, but shows liver metastases. Image courtesy of Stanford University.

News | PET-MRI | June 20, 2017
Simultaneous injections of the radiopharmaceuticals fluorine-18 fluorodeoxyglucose (18F-FDG) and 18F-sodium fluoride (...
Combined Optical and Molecular Imaging Could Guide Breast-Conserving Surgery

WLE specimen from a patient with a grade 3, ER-/HER2-, no special type (NST) carcinoma. (A) Cerenkov image; (B) Grey-scale photographic image overlaid with Cerenkov signal. An increased signal from the tumor is visible (white arrows); mean radiance is 871 ± 131 photons/s/cm2/sr, mean TBR is 3.22. Both surgeons measured the posterior margin (outlined in blue) as 2 mm (small arrow); a cavity shaving would have been performed if the image had been available intraoperatively. The medial margin (outlined in green) measured >5 mm by both surgeons. Pathology ink prevented assessing the lateral margin; a phosphorescent signal is visible (open arrows). (C) Specimen radiography image. The absence of one surgical clip to mark the anterior margin, and the odd position of the superior margin clip (white arrow) prevented reliable margin assessment. (D) Combined histopathology image from two adjacent pathology slides on which the posterior margin (bottom of image) and part of the primary tumor are visible (open arrows). The distance from the posterior margin measured 3 mm microscopically (double arrow). The medial margin is > 5 mm (not present in image). Credit: A. D. Purushotham, M.D., King’s College London, UK

News | Nuclear Imaging | June 20, 2017
June 20, 2017 — Breast-conserving surgery (BCS) is the primary treatment for early-stage...
Overlay Init